拜瑞妥早上吃还是中午吃？

(Rivaroxaban) is a new type of oral anticoagulant with safe, effective, simple and intuitive anticoagulant effects. Therefore, in clinical practice, Xarelto has gradually replaced warfarin as the anticoagulant of choice for venous thrombosis, atrial fibrillation, pulmonary embolism and other diseases. But good medicines must also be taken in the correct way. Today we will learn more about Xarelto in the morning or at noon?

Xarelto (rivaroxaban) to prevent venous thrombosis in adults undergoing elective hip or knee replacement surgery

The recommended dose is 10 mg of Xarelto taken orally once daily. If the wound has stopped bleeding, the first dose of medication should be between 6 and 10 hours after surgery.

For patients undergoing major hip surgery, the recommended course of treatment is 35 days. For patients undergoing major knee surgery, the recommended course of treatment is 12 days. If a missed dose occurs, patients should take Xarelto immediately and continue taking the dose once daily the next day.

  For use in adult patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism

The recommended dose of Xarelto is 20 mg once a day, which is also the maximum recommended dose. For patients with low body weight and advanced age (>75 years old), doctors can use 15 mg once a day as appropriate based on the patient's condition.

Xarelto treats DVT (venous thrombosis) and reduces the risk of acute DVT recurrence and PE

The recommended dose for initial treatment of acute DVT is 15 mg twice daily for the first three weeks, followed by 20 mg once daily for maintenance treatment and to reduce the risk of recurrent DVT and PE. 

Since Xarelto (rivaroxaban) cannot directly act on already produced thrombin, physiological hemostasis is less affected by it. The peak plasma concentration can be reached 2 to 4 hours after patients take this drug orally. It has the characteristics of strong anticoagulation such as rapid onset of action and rapid metabolism, and does not require monitoring of coagulation function. In China, Xarelto was first approved for the prevention and treatment of venous thromboembolic disease. As people's understanding of it deepens, this drug is more and more widely used in clinical treatment.

The above is the content of how to take Rivaroxaban. I hope it can help you!

Recommended related hot articles: /newsDetail/76628.html